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ABSTRACT
The hepatoprotective effects of  matoa leaves were evaluated by paracetamol-induced injury in rat’s hepatocytes. The  ethanolic  extract 
of  matoa leaves (EEML) at doses of  200, 300, 500 mg/kg, po and silymarin at dose of  100 mg/kg, po were given for seven days. Sily-
marin was given as  the  reference  drug. Hepatoprotective  effect  was  studied  by  measuring  the level  of  AST, ALT, ALP and total 
protein in  serum. In vivo, oral treatment with EEML at dose of  500 mg/kg significantly reduced AST, ALT, ALP in serum whereas total 
protein was not significantly reduce in each groups.  These  results indicate that the hepatoprotective action of  EEML is likely related 
to its potent antioxidative activity. Neutralizing reactive oxygen species enhancing the activity of  original natural hepatic-antioxidant 
enzymes may be the main mechanisms of  EEML against paracetamol-induced injury.
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1. INTRODUCTION
Liver is the vital organ that has major roles in metabolism, detox-
ification and elimination of  toxic substances and Liver disease  is 
still   a major health problem (Adewusi and Afolayan, 2010). Free 
radicals are the major risk factor which lead to liver disease (Valko, 
et al., 2007). Paracetamol is a safe and effective analgesic and an-
tipyretic drug. However, an overdose can cause hepatotoxicity in 
experimental animals and humans. Paracetamol hepatotoxicity is 
the most frequent cause of  acute liver failure of  any etiology in the 
western world (Larson et al., 2005; Larson, 2007). 
Paracetamol toxicity is due to the formation of  N-acetyl p-ben-
zoquinone imine (NAPQI) when a part of  it is metabolized by cy-
tochrome P450. NAPQI is a reactive metabolite of  paracetamol, 
detoxified by glutathione (GSH) resulting in extensive hepatic 
GSH depletion. An overdose of  paracetamol causes increasing 
amount of  NAPQI and reacts with protein sulfhydryl groups, 
causing the covalent adduction of  cellular proteins and  causes 
oxidative stress and glutathione (GSH) depletion (Knight et al., 
2001). Synthetic  drugs  used  in  the  treatment  of   liver  diseases 
are  inadequate  and  sometimes can  have  serious  side  effects 
(Prakash, et al., 2008). So, we attempted to evaluate alternative 
medicines as hepatoprotector from medicinal plants. One of  the 
most popular models to evaluate the hepatoprotective potential of  
natural products is paracetamol-induced liver injury (Jaeschke, et 
al., 2013).
Matoa leaves (Pometia pinnata) contains antioxidant. Previous 
study by Suedee et al, 2013 succeed to isolate epicatechin, kaemp-
ferol-3-O-rhamnoside,  quercetin-3-O-rhamnoside, glycolipid, 
1-O-palmitoyl-3-O-[A-galactopyranosyl- (1→6)-β-galactopyra-
nosyl]-sn-glycerol,  steroid glycosides,  stigmasterol-3-O-glucoside 
and   triterpenoid saponin  pentacyclic,  3-O-α-arabinofurano-
syl-(1→3)-[α-rhamnopyranosyl- (1→2)]-α-arabinopyranosyl hed-
eragenin from matoa leaves extract. A potential of  hepatoprotec-
tive property underlying matoa leaves may be attributed to the 
antioxidative constituents (Akachi, et al., 2010).  The bioactive 
compounds that are responsible for relieving oxidative stress  are 
usually indistinctly ascribed to polyphenols and flavonoids com-
pounds (Li, et al., 2015). Hence an attempt has been made to as-
sess the hepatoprotective role of   Matoa leaves.
2. EXPERIMENTAL SECTION
2.1. Chemicals
Paracetamol (acetaminophen), Hepa-Q® capsule (silymarin), 
and standard assay kits of  aspartate transaminase (AST), alanine 
transaminase (ALT), alkaline phosphatase (ALP), bilirubin and to-
tal protein was obtained from Health Laboratory in Palembang. 
All other reagents were analytical grade.
2.2. Plant materials
The matoa leaves were collected from Indralaya, Ogan Ilir Dis-
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trict South Sumatra, Indonesia. The sample was determined in 
Herbarium Departement of  Biology, Faculty of  Mathematics 
and Natural Science Andalas University. Sample was thoroughly 
washed with tap water, sorted while wet, cut dried at 50°C for 5 
days, and grinded into powder (Purwidyaningrum, et al., 2017).
2.3. Preparation of  extract
Sample was extracted by maceration with 96% ethanol . 1 kg of  
crude extract was maceration with 1.5 L of  96% ethanol for 3 
days at  room  temperature  on  a  shake. Done triplicate. The 
filtrate  was  collected,  and  then  evaporated using a rotary vac-
uum evaporator at 45°C under reduced pressure and speed of  40 
rpm to give a viscous extract and then freeze dried to give a dried 
extract. The extract was called EEML (Sihotang, et al., 2016).
2.4. Phytochemical screening
Phytochemical screening was carried out by standard procedures, 
as described by Harborne (1998) and Bargah (2015). The color 
intensity or the precipitate formation was used as analytical re-
sponses to these tests.
2.5. Test for Alkaloids
About 3 ml of  extract was stirred with 3 ml of  1% HCl on steam 
bath. 1  ml  of   mixture  was  taken  separately  in  two  test  tubes. 
Few  drops  of   Dragendorff’s  reagent  were  added  in  one  tube 
and  occurrence  of   orange  red  precipitated  was  taken  as  posi-
tive.  Two   the   second   tube   Mayer’s   reagent   was   added   and 
appearance  of   buff  colored  precipitate  was  taken  as  positive 
test for presence of  alkaloids.
2.6. Test for flavonoids
To  1  ml  of   extract,  1ml  of   10%  lead  acetate  solution  was 
added.  The  formation  of   a  yellow  precipitate  was  taken  as  a 
positive test for presence of  flavonoids.
2.7. Test for tannins
About  2  ml  of   the  extract  was  stirred  with  2ml  of   distilled 
water  and  few  drops  of   ferric  chloride  (FeCl
3
)  solution  were 
added.   Formation   of    green   precipitate   was   indication   of  
presence of  tannins.
2.8. Test for Saponins
About 5  ml  of   extract  was  shaken  vigorously  with  5  ml  of  
distilled water in a test tube and warmed. The formation of  stable 
foam was taken as an indication of  the presence of  saponins.
2.8. Test for Terpenoids
About 2 ml of  the organic extract was dissolved in 2ml of  CHCl
3
 
and evaporated  to  dryness.  2 ml  of   conc.  H
2
SO
4
  was  then 
added  and  heated  for  about  2  minutes.  Development  of   a 
grayish  color indicates the presence of  terpenoids.
2.9. Test for Steroids
Liebermann  Burchard  test:  Development  of   a  greenish color 
when  2  ml  of   the  organic  extract  was  dissolved  in  2  ml  of  
chloroform  and  treated  with  concentrated  sulphuric acid and 
acetic acid indicates the presence of  steroids.
2.10. Experimental animals
Albino adult Wister male rats (150–200 g) were  used  for  this 
study. Animals  were  divided  into  six  groups  (n  =  6/group) 
as  follows: Group I:  normal  control  rats  received Na CMC 1% 
b/v  5  mL/kg b.w. orally for 7  days. Group II: rats received par-
acetamol  3 g/ kg b.w orally  for 2 days. Group III: rats  received 
the  standard  drug  silymarin  100  mg/kg  b.w. orally for 7  days. 
Group IV:  rats  received  sample EEML 200  mg/kg b.w. orally 
for 7  days. Group V:  rats  received  sample EEML 300  mg/kg 
b.w. orally for 7  days. Group VI:  rats  received  sample EEML 
500  mg/kg b.w. orally for 7  days.  
All  the  animals  in  the  groups  III–VI  were  pre-treated 
with EEML from 1st day to 5th day  with  concurrent  administra-
tion  of   paracetamol on 6th and 7th day.  During  the  period  of  
EEML,  the  rats  were maintained under normal diet and water 
ad libitum. After  2  days of   respective  drug  treatments,  animals 
were  anaesthetized  using diethyl  ether  inhalation  jar.  Blood 
was  collected  through  retro-orbital plexus under mild ether an-
esthesia (Prakash, et al., 2008).
2.11. Determination  of   key  liver biochemical mark-
ers
Liver  biochemical  markers  such  as  ALT,  AST,  ALP, and  total 
protein  have  been  evaluated  in  the  serum. Blood was obtained 
from all animals by puncturing the retro-orbital plexus. Blood 
samples were allowed to clot for 45 min at room temperature. Se-
rum was separated by centrifugation at 2.5 x g at 30°C for 15 min 
and assayed for AST, ALT, ALP, and total protein as shown in Ta-
ble 2. (Rajasekaran and Periyasamy, 2012; Abirami, et al., 2015). 
2.12. Statistical analysis
All  data were expressed as mean±standard deviation. Statistical 
analysis was performed using one-way analysis of  variance fol-
lowed by post hoc Tukey. Significant differences were set at values 
<0.05.
3. RESULT AND DISCUSSION
The results of  phytochemical screening of  Matoa Leaves (Pome-
tia pinnata) is presented in Table 1.  The etanol extract of  matoa 
leaves (Pometia pinnata) contains  flavonoids., saponins., tannins., 
and triterpenoid/ steroid. Phenolic and flavonoid compounds of  
plant extracts are recognized as active substances responsible for 
the antioxidant activity due to their free radical scavenging effects 
(Li Yin, et al., 2014).
The result of  Determination  of   key  liver biochemical mark-
ers are shown in Table 2. The effects of  the oral treatment of  
EEML on the serum AST, ALT, ALP, and total protein levels of  
Table 1.The result of  phytochemical screening
No Screening Simplex EEML
1 Alkaloids - -
2 Flavonoids + +
3 Saponins + +
4 Tannins + +
5 Triterpenoid/ steroid + +
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hepatic-damaged rats are shown in Table 2. The serum AST, 
ALT, and ALP levels of  the paracetamol group were elevated, 
whereas the total protein of  this group were not reduced, thus 
indicating that liver cell damage was significantly induced. The 
enhancement of  EEML doses  significantly attenuated the par-
acetamol-induced elevation of  the AST,  ALT, and ALP levels. 
These data suggest that EEML reduced the paracetamol-induced 
hepatic damage.
Paracetamol  (acetaminophen)  is  widely  consumed  as  an 
antipyretic  drug  that  is  safe  in  therapeutic  doses  but  can  cause 
fatal  hepatic  damage  in  human  and  animal  at  higher  toxic 
doses.  Bioactivation  of   paracetamol  by  hepatic  cytochrome 
P-450  leads  to  formation  of   a  highly  reactive  and  toxic  me-
tabolite N-acetyl-p-benzoquinone  imine  (NAPQI). NAPQI  is 
normally detoxified  by  conjugation  with  reduced  glutathione 
(GSH)  to form  mercapturic  acid  which  is  excreted  in  urine 
(Abirami,, et al., 2015).  
Toxic  overdose of   paracetamol  depletes  hepatic  GSH  con-
tent  so  that  free  NAPQI binds  covalently  to  cellular  mitochon-
drial  proteins  and  results  in massive  necrosis  and  apoptosis 
of   hepatocytes  (Chen,, et al., 2009., Bhattacharyya, et al., 2013). 
An  obvious  sign  of   hepatic  injury  is  the  leaking  of   cellular 
enzymes such  as  ALT,  AST  and  ALP  into  plasma. ALT  is 
more specific  to  the  liver,  and  it  is  a  better  parameter  for  ana-
lyzing hepatic  injury.  High  levels  of   AST  indicate  the  cellular 
leakage as  well  as  loss  of   functional  ability  of   cell  membrane 
in  liver. Serum  ALP  is  also  related  with  liver  cell  damage. 
High  concentration  of   ALP  cause  serious  hepatic  damage  in 
paracetamol treated  rats  (Darbar, et al., 2011). 
The  mechanism  of   hepatoprotection  by EEML is  due 
to  their  antioxidant  potential.  This  suggests  that  EEDM can 
reduce  ROS  that  may  lessen  the  oxidative  damage  to  the 
hepatocytes  and  improve  the  activities  of   the  liver  antioxidant 
enzymes,  thus  protecting  the  liver  from  paracetamol  induced 
damage (Valko, et al., 2007). Also,  the  possible  mechanism  could 
be  by  the  stimulation  of   hepatic  regeneration  through  an 
improved  synthesis of   protein  or  accelerated  detoxification  and 
excretion.  (Akachi, et al., 2010).  
4. CONCLUSION
Oral treatment with EEML at dose of  500 mg/kg significantly 
reduced AST, ALT, ALP in serum whereas total protein was not 
significantly reduce.  These results indicate that the hepatopro-
tective action of  EEML is likely related to its potent antioxidative 
activity. It  can  be  concluded  in  our  study  that  etanol extract 
of  matoa leaves (Pometia pinnata)  may  have  a  protective  effect 
against  paracetamol  induced  hepatotoxicity  in  rats.  
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